Nyxoah SA (NYXH) vs Pro-Dex (PDEX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Pro-Dex (PDEX) has outperformed Nyxoah SA (NYXH) over the past year, gaining 79.1% versus a loss of 77.9%. Over five years, PDEX leads with a +142.0% price change compared with -94.7% for NYXH. Pro-Dex is the larger company by market cap ($201.1 million vs $137.5 million), about 1.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NYXH | PDEX |
|---|---|---|
| Share price | $1.35 | $62.21 |
| Market cap | $137.48M | $201.14M |
| 1-day change | -4.93% | -0.94% |
| YTD return | -70.65% | +61.67% |
| 1-year return | -77.87% | +79.07% |
| 5-year return | -94.71% | +141.97% |
| P/E ratio (TTM) | — | 15.10 |
| Forward P/E | — | 18.51 |
| EPS (TTM) | $-2.56 | $4.12 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.88 | $77.00 |
| 52-week low | $1.26 | $23.47 |
| Distance from 52-week high | -80.36% | -19.21% |
| Analyst consensus | none | none |
| Avg. price target upside | +211.11% | +18.95% |
| Average volume | 275.85K | 81.57K |
| Shares outstanding | 101.84M | 3.23M |
| Employees | 153 | 201 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PDEX has outperformed NYXH by 156.9 percentage points over the past year.
About Nyxoah SA
NYXH stock →Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea.
Health Care · Medical/Dental Instruments · 153 employees
About Pro-Dex
PDEX stock →Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide.
Health Care · Medical/Dental Instruments · 201 employees
NYXH vs PDEX FAQ
Which is bigger, Nyxoah SA or Pro-Dex?
Pro-Dex (PDEX) is larger, with a market capitalization of $201.14M compared with $137.48M for Nyxoah SA (NYXH).
Which stock has performed better over the past year, NYXH or PDEX?
PDEX returned +79.07% over the past 12 months, compared with -77.87% for NYXH (price return, excluding dividends). Past performance does not predict future results.
Are Nyxoah SA and Pro-Dex in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.